| Field | Row 1 |
|---|---|
| adsh | 0000950170-25-085143 |
| cik | 1980845 |
| name | ENGENE HOLDINGS INC. |
| sic | 2836 |
| countryba | CA |
| stprba | QC |
| cityba | SAINT-LAURENT |
| zipba | H4R 2P1 |
| bas1 | 4868 RUE LEVY, SUITE 220 |
| bas2 | |
| baph | (514) 332-4888 |
| countryma | CA |
| stprma | QC |
| cityma | SAINT-LAURENT |
| zipma | H4R 2P1 |
| mas1 | 4868 RUE LEVY, SUITE 220 |
| mas2 | |
| countryinc | CA |
| stprinc | |
| ein | 000000000 |
| former | |
| changed | |
| afs | 4-NON |
| wksi | 0 |
| fye | 1031 |
| form | 10-Q |
| period | 20250430 |
| fy | 2025 |
| fp | Q2 |
| filed | 20250612 |
| accepted | 2025-06-12 08:08:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | engn-20250430_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0000950170-25-085143 | 20250430 | Accounts Payable Current | 1567000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Earnings Per Share Basic | 0.5100 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Increase Decrease In Accounts Payable | -689000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 2057000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 1353000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Issuance Of Common Stock In Connection With Pipe Financing Shares | 20000000.0000 | shares | 1 | 0000950170-25-085143 | Equity Components= Common Stock; | ||
| 0000950170-25-085143 | 20250131 | Net Income Loss | -24616000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-085143 | 20241031 | Operating Lease Liability Current | 423000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20231231 | Operating Lease Right Of Use Asset | 400000.0000 | USD | 0 | us-gaap/2024 | Property Plant And Equipment By Type= Office Space; | ||
| 0000950170-25-085143 | 20250430 | Operating Lease Right Of Use Asset | 1640000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | 306000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Other Nonoperating Income Expense | 27000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Restricted Investments | 72000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Share Based Compensation | 4459000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20231031 | Shares Outstanding | 23197976.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-085143 | 20240131 | Shares Outstanding | 23197976.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-085143 | 20231031 | Stockholders Equity | -1016000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-085143 | 20240131 | Stockholders Equity | 62385000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240131 | Stockholders Equity | -210299000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-085143 | 20250430 | Stockholders Equity | 227291000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Stock Issued During Period Shares Stock Options Exercised | 93291.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-085143 | 20250430 | Stock Issued During Period Shares Stock Options Exercised | 94175.0000 | shares | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Stock Issued During Period Value Stock Options Exercised | 207000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-085143 | 20240430 | Stock Issued During Period Value Warrants Exercised | 5983000.0000 | USD | 1 | 0000950170-25-085143 | |||
| 0000950170-25-085143 | 20240430 | Warrant Value Issued As Part Of Amended Term Loan | 319000.0000 | USD | 2 | 0000950170-25-085143 | |||
| 0000950170-25-085143 | 20250430 | Weighted Average Number Of Shares Outstanding Basic | 50997987.0000 | shares | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250131 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | 1809000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Accretion Amortization Of Discounts And Premiums Investments | 1977000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Accumulated Other Comprehensive Income Loss Net Of Tax | -969000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Assets | 266651000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Assets Current | 227974000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Cash And Cash Equivalents At Carrying Value | 57545000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Comprehensive Income Net Of Tax | -25509000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Earnings Per Share Basic | 0.3800 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Earnings Per Share Diluted | 0.8200 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -50173000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Interest Expense Nonoperating | 728000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Interest Expense Nonoperating | 1291000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20241031 | Long Term Notes Payable | 22473000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Marketable Securities Noncurrent | 34109000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Net Cash Provided By Used In Investing Activities | -67017000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Net Cash Provided By Used In Operating Activities | -21532000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240131 | Net Income Loss | -10711000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Notes Payable Current | 3570000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Operating Expenses | 17310000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Payment Of Reverse Recapitalization And Pipe Financing Costs | 613000.0000 | USD | 2 | 0000950170-25-085143 | |||
| 0000950170-25-085143 | 20240430 | Payments Of Debt Issuance Costs | 585000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Payments To Acquire Property Plant And Equipment | 685000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Prepaid Expense And Other Assets Current | 9977000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Proceeds From Issuance Of Debt | 22500000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Property Plant And Equipment Net | 1553000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Repayments Of Term Loan Principal | 9445000.0000 | USD | 2 | 0000950170-25-085143 | |||
| 0000950170-25-085143 | 20241031 | Restricted Investments | 72000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Share Based Compensation | 2208000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20231031 | Stockholders Equity | -199588000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-085143 | 20240430 | Stockholders Equity | -1016000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-085143 | 20250430 | Stockholders Equity | 510121000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-085143 | 20250430 | Stock Issued During Period Value Stock Options Exercised | -109000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-085143 | 20250430 | Weighted Average Number Of Diluted Shares Outstanding | 51019363.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250131 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | 1809000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-085143 | 20240131 | Adjustments To Additional Paid In Capital Warrant Issued | 319000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-085143 | 20241031 | Assets Current | 247362000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20231031 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 81521000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 264810000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 183289000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Comprehensive Income Net Of Tax | -14984000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Comprehensive Income Net Of Tax | -49981000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 1000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | General And Administrative Expense | 6915000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | 2565000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | 37000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Interest Paid Net | 1046000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Investment Income Interest | 4009000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Investment Income Interest | 2488000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Issuance Of Common Stock In Connection With Pipe Financing Value | 187614000.0000 | USD | 1 | 0000950170-25-085143 | |||
| 0000950170-25-085143 | 20241031 | Liabilities | 38561000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Net Cash Provided By Used In Financing Activities | 205505000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250131 | Net Income Loss | -24616000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Nonoperating Income Expense | 2347000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20241031 | Notes Payable Current | 700000.0000 | USD | 0 | us-gaap/2024 | Counterparty Name= Hercules Capital; Debt Instrument= Loan And Security Agreement; | ||
| 0000950170-25-085143 | 20250430 | Notes Payable Current | 3600000.0000 | USD | 0 | us-gaap/2024 | Counterparty Name= Hercules Capital; Type Of Arrangement= Loan And Security Agreements; | ||
| 0000950170-25-085143 | 20250430 | Operating Income Loss | -27124000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Operating Lease Liability Current | 431000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20241031 | Operating Lease Liability Noncurrent | 1427000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Operating Lease Liability Noncurrent | 1336000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Other Nonoperating Income Expense | -168000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240131 | Stockholders Equity | -1016000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-085143 | 20250131 | Stockholders Equity | -1275000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-085143 | 20240430 | Stock Issued During Period Shares Cashless Exercise Of Warrants | 383355.0000 | shares | 1 | 0000950170-25-085143 | Equity Components= Common Stock; | ||
| 0000950170-25-085143 | 20240430 | Stock Issued During Period Value Cashless Exercise Of Warrants | -97000.0000 | USD | 1 | 0000950170-25-085143 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-085143 | 20250131 | Stock Issued During Period Value Stock Options Exercised | 1000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Stock Issued During Period Value Stock Options Exercised | 309000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-085143 | 20240430 | Stock Issued During Period Value Warrants Exercised | -131000.0000 | USD | 1 | 0000950170-25-085143 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-085143 | 20240430 | Stock Issued During Period Value Warrants Exercised | 6114000.0000 | USD | 1 | 0000950170-25-085143 | Equity Components= Common Stock; | ||
| 0000950170-25-085143 | 20250430 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | 2650000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 57545000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20241031 | Common Stock No Par Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Common Stock Shares Outstanding | 51070851.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Comprehensive Income Net Of Tax | -25695000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Earnings Per Share Basic | 0.9900 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Earnings Per Share Diluted | 0.3800 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 1000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Gains Losses On Extinguishment Of Debt | -366000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Income Tax Expense Benefit | 21000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Income Tax Expense Benefit | 258000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Increase Decrease In Investment Tax Credit Receivable | -1130000.0000 | USD | 2 | 0000950170-25-085143 | |||
| 0000950170-25-085143 | 20250430 | Increase Decrease In Operating Lease Liability | -88000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20241031 | Investment Tax Credits Receivable | 332000.0000 | USD | 0 | 0000950170-25-085143 | |||
| 0000950170-25-085143 | 20241031 | Liabilities And Stockholders Equity | 311173000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20241031 | Liabilities Current | 14661000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Liabilities Current | 18001000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Net Cash Provided By Used In Financing Activities | 200000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240131 | Net Income Loss | -10711000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-085143 | 20250430 | Non Cash Interest Expense | 427000.0000 | USD | 2 | 0000950170-25-085143 | |||
| 0000950170-25-085143 | 20240430 | Nonoperating Income Expense | 2379000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20241031 | Operating Lease Right Of Use Asset | 1741000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20241031 | Other Assets Noncurrent | 1374000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | 306000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-085143 | 20250430 | Proceeds From Sale And Maturity Of Available For Sale Securities | 41750000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Research And Development Expense | 20209000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20231031 | Stockholders Equity | 13717000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-085143 | 20240430 | Stockholders Equity | 242966000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Stock Issued During Period Shares Stock Options Exercised | 56974.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-085143 | 20240430 | Stock Issued During Period Value Stock Options Exercised | 51000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Stock Issued During Period Value Stock Options Exercised | -156000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-085143 | 20250430 | Weighted Average Number Of Diluted Shares Outstanding | 50997987.0000 | shares | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20241031 | Additional Paid In Capital Common Stock | 18950000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240131 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | 291000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Foreign Currency Transaction Gain Loss Unrealized | -8000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | General And Administrative Expense | 12590000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | General And Administrative Expense | 13554000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -25575000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Increase Decrease In Investment Tax Credit Receivable | 200000.0000 | USD | 2 | 0000950170-25-085143 | |||
| 0000950170-25-085143 | 20240430 | Increase Decrease In Operating Lease Liability | 35000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Investment Income Interest | 2984000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Issuance Of Common Stock In Connection With Pipe Financing Value | 187614000.0000 | USD | 1 | 0000950170-25-085143 | Equity Components= Common Stock; | ||
| 0000950170-25-085143 | 20250430 | Liabilities | 39360000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20241031 | Marketable Securities Current | 65328000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20241031 | Marketable Securities Noncurrent | 59527000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Net Income Loss | -14984000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-085143 | 20240430 | Non Cash Interest Expense | 372000.0000 | USD | 2 | 0000950170-25-085143 | |||
| 0000950170-25-085143 | 20250430 | Nonoperating Income Expense | 1549000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Nonoperating Income Expense | 3564000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Operating Income Loss | -53737000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250131 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | 144000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Payments To Acquire Marketable Securities | 108423000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Proceeds From Stock Options Exercised | 51000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250131 | Shares Outstanding | 50977560.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-085143 | 20250430 | Shares Outstanding | 51070851.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-085143 | 20231031 | Stockholders Equity | 259373000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-085143 | 20241031 | Stockholders Equity | 509811000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-085143 | 20250131 | Stockholders Equity | 20759000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-085143 | 20250430 | Stockholders Equity | 23300000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-085143 | 20240430 | Stock Issued During Period Value Cashless Exercise Of Warrants | 97000.0000 | USD | 1 | 0000950170-25-085143 | Equity Components= Common Stock; | ||
| 0000950170-25-085143 | 20250430 | Weighted Average Number Of Shares Outstanding Basic | 51019363.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20241031 | Accounts Payable Current | 1411000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20241031 | Accrued Liabilities And Other Liabilities | 12128000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240131 | Adjustments To Additional Paid In Capital Warrant Issued | 319000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20241031 | Common Stock Shares Issued | 50976676.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Earnings Per Share Diluted | 0.9900 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Gains Losses On Extinguishment Of Debt | 400000.0000 | USD | 2 | us-gaap/2024 | Credit Facility= Term Loan; Type Of Arrangement= Amended Loan Agreement; | ||
| 0000950170-25-085143 | 20250430 | Increase Decrease In Accounts Payable | 152000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Interest Expense Nonoperating | 1486000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Interest Paid Net | 867000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Investment Tax Credits Receivable | 533000.0000 | USD | 0 | 0000950170-25-085143 | |||
| 0000950170-25-085143 | 20250430 | Long Term Notes Payable | 20023000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Net Income Loss | -25815000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20241031 | Notes Payable Current | 699000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Operating Expenses | 28083000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Operating Expenses | 27124000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Operating Income Loss | -28083000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20221231 | Operating Lease Right Of Use Asset | 1400000.0000 | USD | 0 | us-gaap/2024 | Property Plant And Equipment By Type= New Laboratory And Office Space; | ||
| 0000950170-25-085143 | 20250430 | Other Assets Noncurrent | 1375000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | 306000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Payments To Acquire Property Plant And Equipment | 344000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20241031 | Prepaid Expense And Other Assets Current | 8626000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Proceeds From Issuance Of Private Placement | 200000000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Proceeds From Stock Options Exercised | 200000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Proceeds From Warrant Exercises | 5983000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Research And Development Expense | 9855000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240131 | Stockholders Equity | 14327000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-085143 | 20241031 | Stockholders Equity | 272612000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250131 | Stockholders Equity | 249950000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250131 | Stockholders Equity | 509812000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-085143 | 20250430 | Stock Issued During Period Value Stock Options Exercised | 200000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20241031 | Accumulated Other Comprehensive Income Loss Net Of Tax | -1419000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Additional Paid In Capital Common Stock | 23300000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240131 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | 291000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-085143 | 20240430 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | 1917000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | 1917000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-085143 | 20241031 | Assets | 311173000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20241031 | Cash And Cash Equivalents At Carrying Value | 173004000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Common Stock No Par Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Common Stock Shares Issued | 51070851.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20241031 | Common Stock Shares Outstanding | 50976676.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20241031 | Common Stock Value | 509811000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Common Stock Value | 510121000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Depreciation | 208000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Earnings Per Share Diluted | 0.5100 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Foreign Currency Transaction Gain Loss Unrealized | -21000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | General And Administrative Expense | 7455000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -14963000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Income Tax Expense Benefit | 240000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Investment Income Interest | 5218000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Liabilities And Stockholders Equity | 266651000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Marketable Securities Current | 159847000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Net Cash Provided By Used In Investing Activities | -685000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Net Cash Provided By Used In Operating Activities | -48643000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Net Income Loss | -25815000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-085143 | 20250430 | Non Cash Lease Expenses | -102000.0000 | USD | 2 | 0000950170-25-085143 | |||
| 0000950170-25-085143 | 20240430 | Operating Income Loss | -17310000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Other Nonoperating Income Expense | -205000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20241031 | Property Plant And Equipment Net | 1169000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Research And Development Expense | 15493000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20241031 | Retained Earnings Accumulated Deficit | -254730000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240131 | Stockholders Equity | 259373000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-085143 | 20240430 | Stockholders Equity | -225283000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-085143 | 20241031 | Stockholders Equity | 18950000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-085143 | 20250131 | Stockholders Equity | -279346000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-085143 | 20250430 | Stockholders Equity | -305161000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-085143 | 20240430 | Weighted Average Number Of Diluted Shares Outstanding | 39443768.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Weighted Average Number Of Shares Outstanding Basic | 31186238.0000 | shares | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Accrued Liabilities And Other Liabilities | 12433000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Capital Expenditures Incurred But Not Yet Paid | 249000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20241031 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 173004000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -115459000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Depreciation | 158000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Earnings Per Share Basic | 0.8200 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -25704000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Income Tax Expense Benefit | -9000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Interest Expense Nonoperating | 734000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Net Income Loss | -14984000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Net Income Loss | -25695000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Net Income Loss | -50431000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Non Cash Lease Expenses | -67000.0000 | USD | 2 | 0000950170-25-085143 | |||
| 0000950170-25-085143 | 20250430 | Operating Expenses | 53737000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | 450000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250131 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | 144000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-085143 | 20240430 | Other Nonoperating Income Expense | 91000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Payments Of Issuance Costs Associated With The Pipe Financing | 12386000.0000 | USD | 2 | 0000950170-25-085143 | |||
| 0000950170-25-085143 | 20240430 | Profit Loss | -25695000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Profit Loss | -50431000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Research And Development Expense | 40183000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20250430 | Retained Earnings Accumulated Deficit | -305161000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Right Of Use Asset Obtained In Exchange For Operating Lease Liability | 1904000.0000 | USD | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Shares Outstanding | 44158587.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-085143 | 20241031 | Shares Outstanding | 50976676.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-085143 | 20231031 | Stockholders Equity | 72486000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Stockholders Equity | 15860000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-085143 | 20240430 | Stockholders Equity | 453405000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-085143 | 20241031 | Stockholders Equity | -1419000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-085143 | 20241031 | Stockholders Equity | -254730000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-085143 | 20250430 | Stockholders Equity | -969000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-085143 | 20250131 | Stock Issued During Period Shares Stock Options Exercised | 884.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-085143 | 20240430 | Stock Issued During Period Shares Warrants Exercised | 520282.0000 | shares | 1 | 0000950170-25-085143 | Equity Components= Common Stock; | ||
| 0000950170-25-085143 | 20250131 | Stock Issued During Period Value Stock Options Exercised | 1000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-085143 | 20240430 | Weighted Average Number Of Diluted Shares Outstanding | 31186238.0000 | shares | 2 | us-gaap/2024 | |||
| 0000950170-25-085143 | 20240430 | Weighted Average Number Of Shares Outstanding Basic | 39443768.0000 | shares | 1 | us-gaap/2024 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Adjustments To Additional Paid In Capital Warrant Issued | us-gaap/2024 | 0 | 0 | monetary | D | C | Adjustments to Additional Paid in Capital, Warrant Issued | Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants. |
| Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | Amount of increase in right-of-use asset obtained in exchange for operating lease liability. |
| Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Investment Tax Credits Receivable | 0000950170-25-085143 | 1 | 0 | monetary | I | D | Investment Tax Credits Receivable | Investment tax credits receivable. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Proceeds From Issuance Of Private Placement | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Private Placement | The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. |
| Proceeds From Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Stock Options Exercised | Amount of cash inflow from exercise of option under share-based payment arrangement. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Repayments Of Term Loan Principal | 0000950170-25-085143 | 1 | 0 | monetary | D | C | Repayments of term loan principal | Repayments of term loan principal. |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Long Term Notes Payable | us-gaap/2024 | 0 | 0 | monetary | I | C | Notes Payable, Noncurrent | Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent | Amount, after tax and reclassification adjustment, of gain (loss) in value of unsold investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent. |
| Payments Of Debt Issuance Costs | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments of Debt Issuance Costs | The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Accrued Liabilities And Other Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Liabilities and Other Liabilities | Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other. |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | D | D | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations | Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Foreign Currency Transaction Gain Loss Unrealized | us-gaap/2024 | 0 | 0 | monetary | D | C | Unrealized Gain (Loss), Foreign Currency Transaction, before Tax | Amount, before tax, of unrealized gain (loss) from foreign currency transaction. |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Other Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
| Non Cash Lease Expenses | 0000950170-25-085143 | 1 | 0 | monetary | D | C | Non Cash Lease Expenses | Non cash lease expenses. |
| Stock Issued During Period Shares Warrants Exercised | 0000950170-25-085143 | 1 | 0 | shares | D | Stock Issued During Period Shares Warrants Exercised | Stock issued during period shares warrants exercised. | |
| Stock Issued During Period Value Warrants Exercised | 0000950170-25-085143 | 1 | 0 | monetary | D | C | Stock Issued During Period Value Warrants Exercised | Stock issued during period value warrants exercised. |
| Interest Expense Nonoperating | us-gaap/2024 | 0 | 0 | monetary | D | D | Interest Expense, Nonoperating | Amount of interest expense classified as nonoperating. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Marketable Securities Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Marketable Securities, Current | Amount of investment in marketable security, classified as current. |
| Proceeds From Issuance Of Debt | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Debt | The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt. |
| Proceeds From Sale And Maturity Of Available For Sale Securities | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale | Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Increase Decrease In Investment Tax Credit Receivable | 0000950170-25-085143 | 1 | 0 | monetary | D | C | Increase (Decrease) In Investment Tax Credit Receivable | Increase (decrease) in investment tax credit receivable. |
| Warrant Value Issued As Part Of Amended Term Loan | 0000950170-25-085143 | 1 | 0 | monetary | D | D | Warrant Value Issued as Part of Amended Term Loan | Warrant value issued as part of amended term loan. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
| Payments Of Issuance Costs Associated With The Pipe Financing | 0000950170-25-085143 | 1 | 0 | monetary | D | C | Payments Of Issuance Costs Associated With The Pipe Financing | Payments of issuance costs associated with the pipe financing. |
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement. |
| Common Stock No Par Value | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, No Par Value | Face amount per share of no-par value common stock. | |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | Amount of increase (decrease) in accrued expenses, and obligations classified as other. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Notes Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Notes Payable, Current | Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Capital Expenditures Incurred But Not Yet Paid | us-gaap/2024 | 0 | 0 | monetary | D | C | Capital Expenditures Incurred but Not yet Paid | Future cash outflow to pay for purchases of fixed assets that have occurred. |
| Stock Issued During Period Value Cashless Exercise Of Warrants | 0000950170-25-085143 | 1 | 0 | monetary | D | C | Stock Issued During Period Value Cashless Exercise Of Warrants | Stock issued during period value cashless exercise of warrants. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Marketable Securities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Marketable Securities, Noncurrent | Amount of investment in marketable security, classified as noncurrent. |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | Amount after tax of other comprehensive income (loss) attributable to parent entity. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Payment Of Reverse Recapitalization And Pipe Financing Costs | 0000950170-25-085143 | 1 | 0 | monetary | D | C | Payment Of Reverse Recapitalization And Pipe Financing Costs | Payment of reverse recapitalization and pipe financing costs. |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Additional Paid In Capital Common Stock | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Gains Losses On Extinguishment Of Debt | us-gaap/2024 | 0 | 0 | monetary | D | C | Gain (Loss) on Extinguishment of Debt | Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. |
| Increase Decrease In Accounts Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Increase Decrease In Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
| Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Other Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
| Issuance Of Common Stock In Connection With Pipe Financing Shares | 0000950170-25-085143 | 1 | 0 | shares | D | Issuance Of Common Stock In Connection With Pipe Financing Shares | Issuance of common stock in connection with PIPE financing shares. | |
| Issuance Of Common Stock In Connection With Pipe Financing Value | 0000950170-25-085143 | 1 | 0 | monetary | D | C | Issuance of Common Stock in Connection With Pipe Financing Value | Issuance of common stock in connection with PIPE financing value |
| Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Accretion (Amortization) of Discounts and Premiums, Investments | The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Depreciation | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Investment Income Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Investment Income, Interest | Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. |
| Payments To Acquire Marketable Securities | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Marketable Securities | Amount of cash outflow for purchase of marketable security. |
| Restricted Investments | us-gaap/2024 | 0 | 0 | monetary | I | D | Restricted Investments | Investments which are not defined as or included in marketable (debt, equity, or other) securities whose use is restricted in whole or in part, generally by contractual agreements or regulatory requirements. For use in an unclassified balance sheet. |
| Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | 0 | 0 | shares | D | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Non Cash Interest Expense | 0000950170-25-085143 | 1 | 0 | monetary | D | D | Non-cash Interest Expense | Non-cash interest expense. |
| Proceeds From Warrant Exercises | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Warrant Exercises | The cash inflow associated with the amount received from holders exercising their stock warrants. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Stock Issued During Period Shares Cashless Exercise Of Warrants | 0000950170-25-085143 | 1 | 0 | shares | D | Stock Issued During Period Shares Cashless Exercise Of Warrants | Stock issued during period shares cashless exercise of warrants. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0000950170-25-085143 | 2 | 5 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0000950170-25-085143 | 2 | 6 | BS | 0 | H | Marketable Securities Current | us-gaap/2024 | Marketable securities - short term | 0 |
| 0000950170-25-085143 | 2 | 7 | BS | 0 | H | Restricted Investments | us-gaap/2024 | Restricted investments | 0 |
| 0000950170-25-085143 | 2 | 8 | BS | 0 | H | Investment Tax Credits Receivable | 0000950170-25-085143 | Investment tax credits receivable | 0 |
| 0000950170-25-085143 | 2 | 9 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid and other current assets | 0 |
| 0000950170-25-085143 | 2 | 10 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0000950170-25-085143 | 2 | 11 | BS | 0 | H | Marketable Securities Noncurrent | us-gaap/2024 | Marketable securities - long term | 0 |
| 0000950170-25-085143 | 2 | 12 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
| 0000950170-25-085143 | 2 | 13 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease right of use asset | 0 |
| 0000950170-25-085143 | 2 | 14 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2024 | Other assets | 0 |
| 0000950170-25-085143 | 2 | 15 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0000950170-25-085143 | 2 | 18 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0000950170-25-085143 | 2 | 19 | BS | 0 | H | Accrued Liabilities And Other Liabilities | us-gaap/2024 | Accrued expenses and other current liabilities | 0 |
| 0000950170-25-085143 | 2 | 20 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Operating lease liabilities, current | 0 |
| 0000950170-25-085143 | 2 | 21 | BS | 0 | H | Notes Payable Current | us-gaap/2024 | Current portion of note payable | 0 |
| 0000950170-25-085143 | 2 | 22 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0000950170-25-085143 | 2 | 23 | BS | 0 | H | Long Term Notes Payable | us-gaap/2024 | Note payable, net of current portion | 0 |
| 0000950170-25-085143 | 2 | 24 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Operating lease liabilities, net of current portion | 0 |
| 0000950170-25-085143 | 2 | 25 | BS | 0 | H | Liabilities | us-gaap/2024 | Liabilities, Total | 0 |
| 0000950170-25-085143 | 2 | 27 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common shares, no par value; unlimited shares authorized, 51,070,851 and 50,976,676 shares issued and outstanding as of April 30, 2025 and October 31, 2024, respectively. | 0 |
| 0000950170-25-085143 | 2 | 28 | BS | 0 | H | Additional Paid In Capital Common Stock | us-gaap/2024 | Additional paid-in capital | 0 |
| 0000950170-25-085143 | 2 | 29 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive loss | 0 |
| 0000950170-25-085143 | 2 | 30 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0000950170-25-085143 | 2 | 31 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total shareholder's equity | 0 |
| 0000950170-25-085143 | 2 | 32 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and shareholders' equity | 0 |
| 0000950170-25-085143 | 3 | 5 | BS | 1 | H | Common Stock No Par Value | us-gaap/2024 | Common stock no par value | 0 |
| 0000950170-25-085143 | 3 | 7 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock shares issued | 0 |
| 0000950170-25-085143 | 3 | 8 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock shares outstanding | 0 |
| 0000950170-25-085143 | 4 | 2 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0000950170-25-085143 | 4 | 3 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative | 0 |
| 0000950170-25-085143 | 4 | 4 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0000950170-25-085143 | 4 | 5 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 1 |
| 0000950170-25-085143 | 4 | 7 | IS | 0 | H | Investment Income Interest | us-gaap/2024 | Interest income | 1 |
| 0000950170-25-085143 | 4 | 8 | IS | 0 | H | Interest Expense Nonoperating | us-gaap/2024 | Interest expense | 0 |
| 0000950170-25-085143 | 4 | 9 | IS | 0 | H | Gains Losses On Extinguishment Of Debt | us-gaap/2024 | Loss on extinguishment of debt | 1 |
| 0000950170-25-085143 | 4 | 10 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2024 | Other expense (income), net | 1 |
| 0000950170-25-085143 | 4 | 11 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Total other income, net | 1 |
| 0000950170-25-085143 | 4 | 12 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Net loss before income taxes | 1 |
| 0000950170-25-085143 | 4 | 13 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Provision for (recovery of) income taxes | 0 |
| 0000950170-25-085143 | 4 | 14 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 1 |
| 0000950170-25-085143 | 4 | 16 | IS | 0 | H | Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | us-gaap/2024 | Unrealized gain on available-for-sale investments | 1 |
| 0000950170-25-085143 | 4 | 17 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Total comprehensive loss (income) | 1 |
| 0000950170-25-085143 | 4 | 18 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net loss per share of common shares, basic | 0 |
| 0000950170-25-085143 | 4 | 19 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net loss per share of common shares, diluted | 0 |
| 0000950170-25-085143 | 4 | 20 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted-average common shares outstanding, basic | 0 |
| 0000950170-25-085143 | 4 | 21 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted-average common shares outstanding, diluted | 0 |
| 0000950170-25-085143 | 5 | 11 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Beginning balance (in shares) | 0 |
| 0000950170-25-085143 | 5 | 12 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Beginning balance | 0 |
| 0000950170-25-085143 | 5 | 13 | EQ | 0 | H | Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | Exercise of stock options (in shares) | 0 |
| 0000950170-25-085143 | 5 | 14 | EQ | 0 | H | Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | Exercise of stock options | 0 |
| 0000950170-25-085143 | 5 | 15 | EQ | 0 | H | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | us-gaap/2024 | Share-based compensation expense | 0 |
| 0000950170-25-085143 | 5 | 16 | EQ | 0 | H | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | us-gaap/2024 | Other comprehensive income (loss) | 0 |
| 0000950170-25-085143 | 5 | 17 | EQ | 0 | H | Issuance Of Common Stock In Connection With Pipe Financing Shares | 0000950170-25-085143 | Issuance of common shares in connection with PIPE Financing, net of issuance costs (in shares) | 0 |
| 0000950170-25-085143 | 5 | 18 | EQ | 0 | H | Issuance Of Common Stock In Connection With Pipe Financing Value | 0000950170-25-085143 | Issuance of common shares in connection with PIPE Financing, net of issuance costs | 0 |
| 0000950170-25-085143 | 5 | 19 | EQ | 0 | H | Stock Issued During Period Shares Warrants Exercised | 0000950170-25-085143 | Issuance of common shares upon exercise of warrants (in shares) | 0 |
| 0000950170-25-085143 | 5 | 20 | EQ | 0 | H | Stock Issued During Period Value Warrants Exercised | 0000950170-25-085143 | Issuance of common shares upon exercise of warrants | 0 |
| 0000950170-25-085143 | 5 | 21 | EQ | 0 | H | Stock Issued During Period Shares Cashless Exercise Of Warrants | 0000950170-25-085143 | Issuance of common shares upon cashless exercise of warrants (in shares) | 0 |
| 0000950170-25-085143 | 5 | 22 | EQ | 0 | H | Stock Issued During Period Value Cashless Exercise Of Warrants | 0000950170-25-085143 | Issuance of common shares upon cashless exercise of warrants | 0 |
| 0000950170-25-085143 | 5 | 23 | EQ | 0 | H | Adjustments To Additional Paid In Capital Warrant Issued | us-gaap/2024 | Issuance of warrants in connection with Amended Term Loan expense | 0 |
| 0000950170-25-085143 | 5 | 24 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0000950170-25-085143 | 5 | 25 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Ending balance (in shares) | 0 |
| 0000950170-25-085143 | 5 | 26 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Ending balance | 0 |
| 0000950170-25-085143 | 6 | 4 | CF | 0 | H | Profit Loss | us-gaap/2024 | Net loss | 0 |
| 0000950170-25-085143 | 6 | 6 | CF | 0 | H | Non Cash Interest Expense | 0000950170-25-085143 | Non-cash interest expense | 0 |
| 0000950170-25-085143 | 6 | 7 | CF | 0 | H | Gains Losses On Extinguishment Of Debt | us-gaap/2024 | Loss on extinguishment of debt | 1 |
| 0000950170-25-085143 | 6 | 8 | CF | 0 | H | Non Cash Lease Expenses | 0000950170-25-085143 | Non-cash lease expense | 1 |
| 0000950170-25-085143 | 6 | 9 | CF | 0 | H | Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2024 | Amortization (accretion) of marketable securities | 1 |
| 0000950170-25-085143 | 6 | 10 | CF | 0 | H | Foreign Currency Transaction Gain Loss Unrealized | us-gaap/2024 | Unrealized foreign currency losses | 1 |
| 0000950170-25-085143 | 6 | 11 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Share-based compensation expense | 0 |
| 0000950170-25-085143 | 6 | 12 | CF | 0 | H | Depreciation | us-gaap/2024 | Depreciation of property and equipment | 0 |
| 0000950170-25-085143 | 6 | 14 | CF | 0 | H | Increase Decrease In Investment Tax Credit Receivable | 0000950170-25-085143 | Investment tax credit receivable | 1 |
| 0000950170-25-085143 | 6 | 15 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other assets | 1 |
| 0000950170-25-085143 | 6 | 16 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2024 | Accounts payable | 0 |
| 0000950170-25-085143 | 6 | 17 | CF | 0 | H | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | us-gaap/2024 | Accrued expenses and other liabilities | 0 |
| 0000950170-25-085143 | 6 | 18 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2024 | Lease liabilities | 0 |
| 0000950170-25-085143 | 6 | 19 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0000950170-25-085143 | 6 | 21 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchases of property and equipment | 1 |
| 0000950170-25-085143 | 6 | 22 | CF | 0 | H | Payments To Acquire Marketable Securities | us-gaap/2024 | Purchases of marketable securities | 1 |
| 0000950170-25-085143 | 6 | 23 | CF | 0 | H | Proceeds From Sale And Maturity Of Available For Sale Securities | us-gaap/2024 | Proceeds from maturities of marketable securities | 0 |
| 0000950170-25-085143 | 6 | 24 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash used in investing activities | 0 |
| 0000950170-25-085143 | 6 | 26 | CF | 0 | H | Payment Of Reverse Recapitalization And Pipe Financing Costs | 0000950170-25-085143 | Payment of Reverse Recapitalization and PIPE Financing costs | 1 |
| 0000950170-25-085143 | 6 | 27 | CF | 0 | H | Proceeds From Issuance Of Private Placement | us-gaap/2024 | Proceeds from the February 2024 PIPE Financing | 0 |
| 0000950170-25-085143 | 6 | 28 | CF | 0 | H | Payments Of Issuance Costs Associated With The Pipe Financing | 0000950170-25-085143 | Payments of issuance costs associated with the 2024 PIPE Financing | 1 |
| 0000950170-25-085143 | 6 | 29 | CF | 0 | H | Proceeds From Warrant Exercises | us-gaap/2024 | Proceeds from exercise of common share warrants | 0 |
| 0000950170-25-085143 | 6 | 30 | CF | 0 | H | Proceeds From Stock Options Exercised | us-gaap/2024 | Proceeds from exercise of stock options | 0 |
| 0000950170-25-085143 | 6 | 31 | CF | 0 | H | Repayments Of Term Loan Principal | 0000950170-25-085143 | Repayments of term loan principal | 1 |
| 0000950170-25-085143 | 6 | 32 | CF | 0 | H | Proceeds From Issuance Of Debt | us-gaap/2024 | Proceeds from issuance of term loan | 0 |
| 0000950170-25-085143 | 6 | 33 | CF | 0 | H | Payments Of Debt Issuance Costs | us-gaap/2024 | Payments of debt issuance costs associated with the term loan | 1 |
| 0000950170-25-085143 | 6 | 34 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
| 0000950170-25-085143 | 6 | 35 | CF | 0 | H | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Effect of exchange rate changes on cash | 0 |
| 0000950170-25-085143 | 6 | 36 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net (decrease) increase in cash and cash equivalents | 0 |
| 0000950170-25-085143 | 6 | 37 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash and cash equivalents at beginning of period | 0 |
| 0000950170-25-085143 | 6 | 38 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash and cash equivalents at end of period | 0 |
| 0000950170-25-085143 | 6 | 40 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Cash paid for interest | 0 |
| 0000950170-25-085143 | 6 | 41 | CF | 0 | H | Warrant Value Issued As Part Of Amended Term Loan | 0000950170-25-085143 | Warrant value issued as part of Amended Term Loan | 0 |
| 0000950170-25-085143 | 6 | 42 | CF | 0 | H | Right Of Use Asset Obtained In Exchange For Operating Lease Liability | us-gaap/2024 | Right of use assets obtained in exchange for lease liabilities | 0 |
| 0000950170-25-085143 | 6 | 43 | CF | 0 | H | Capital Expenditures Incurred But Not Yet Paid | us-gaap/2024 | Property and equipment included in accrued expenses and accounts payable | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |